-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602. Myeloid Oncogenesis: Basic: Poster III

Symposia: Myeloid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Xiang Gao, MD1*, Vegi M. Naidu, PhD2*, Zhong Zhang1*, Ines Sieber1*, Vijay Pal Singh Rawat, PhD3* and Michaela Feuring, MD1*

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Institute For Experimental Cancer Research, Ulm, DEU
3Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India

Aishwarya S Pawar1, Aleena Alex2*, Subin S George2*, Charles Antony, PhD2, Patrick Somers2* and Vikram R Paralkar, MD2

1Biomedical Graduate Studies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Department of Medicine, University of Pennsylvania, Philadelphia, PA

Tiankai Yin, BA, Michael H. Kramer, MD, PhD, Michael Bern, MD, PhD, Nichole Helton*, Daniel George*, Mieke Hoock*, Sai Mukund Ramakrishnan, MS*, Christopher A Miller, PhD* and Timothy J Ley, MD

Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Ke Shang1*, Guangshuai Teng1*, Yuhui Zhang1*, Yifan Duan1*, Chenxiao Du1*, Yan Wang1*, Huiqin Zhang1*, Xuelian Cheng2*, Yuan Zhou3*, Yajing Chu3*, Weiping Yuan1,3 and Jie Bai, MD4

1Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
3State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Institute of Hematology &blood Disease Hospital, Tianjin City, Tianjin City, China

Josiah Murray, BS, MT1,2,3, Lauren Banaag, BS4*, Cary Stelloh5*, Atrayee Ray, PhD5*, Alison E Meyer, PhD6 and Sridhar Rao, MD, PhD1,3,7,8

1Hematopoiesis & Stem Cell Biology Program, Versiti Blood Research Institute, Milwaukee, WI
2Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, West Allis, WI
3Medical Scientist Training Program, Medical College of Wisconsin, Milwaukee, WI
4School of Pharmacy, Medical College of Wisconsin, Milwaukee
5Versiti Blood Research Institute, Milwaukee, WI
6Versiti Blood Research Institute, Brookfield, WI
7Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplantation, Children's Hospital of Wisconsin, Milwaukee
8Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI

Josh R Faust, BSc1,2*, Anilkumar Gopalakrishnapillai, PhD, MSc1,3 and Sonali P Barwe, PhD, MSc1,3

1Nemours Children's Hospital, Wilmington, DE
2Department of Biological Sciences, University of Delaware, Wilmington, DE
3Department of Biological Sciences, University of Delaware, Newark, DE

Luca Guarnera, MD1*, Adam Wahida2*, Carmelo Gurnari, MD, PhD3, Stephan Hutter, PhD4*, Sabine Stainczyk5*, Nakisha D Williams, MBBS1*, Arda Durmaz, PhD6*, Yasuo Kubota, MD, PhD1*, Carlos Bravo-Perez, MD7*, Naomi Kawashima, MD PhD8*, Simona Pagliuca, MD, PhD9, Yimin Huang10*, Thomas Laframboise, PhD11*, Valeria Visconte, PhD12, Wencke Walter, PhD13, Manja Meggendorfer, PhD14, Claudia Haferlach, MD4, Wolfgang Kern, MD4, Frank Westermann5*, Lars Feuerbach, PhD, MSc, BSc15*, Torsten Haferlach, MD4 and Jaroslaw Maciejewski16

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Institute of Metabolism and Cell death, Neuherberg, Germany
3Cleveland Clinic Foundation, Cleveland, OH
4MLL Munich Leukemia Laboratory, Munich, Germany
5Hopp Children’s Cancer Center, Heidelberg, DEU
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, CLEVELAND, OH
7Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
8Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
9Department of Hematology, Nancy University Hospital, Vandœuvre-lès-Nancy, France, France
10Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH
11Case Western Reserve University, Cleveland, OH
12Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Taussig Cancer Institute, Cleveland, OH
13Munich Leukemia Laboratory, Munich, Germany
14MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
15Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, DEU
16Taussig Cancer Center, Cleveland, OH

Lin Han, PhD1,2, Benjamin Braun1,2*, Caroline A. Conway1,2*, Amy Wang1,2, Johann-Christoph Jann, MD1,2*, Yihua Wang1,2*, Kate I. Drachman1,2*, Qingqing Yan, PhD3*, Elodie Hatchi, PhD1,2*, Phillip Wulfridge, PhD3*, William Doyle1,2*, Caroline N. Pitton1,2*, Kavitha Sarma, PhD3* and Zuzana Tothova, MD, PhD1,2

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Cancer Program, Broad Institute, Cambridge, MA
3Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA

Xueqin Xie, PhD1*, Florisela Herrejon Chavez, PhD2*, Ilyes Baali3*, Eren L. Chu, PhD4*, Chiara Evans3*, Xuejing Yang, PhD5*, Wei Wei, MD PhD2*, Hanzhi Luo, PhD5, Sun Mi Park, PhD6*, Kathryn Chang5*, Aspen Pierson5*, Grace Han4*, Emily Batchelor5*, Quaid D. Morris, PhD7*, Ly Vu, PhD8,9,10, Diu T.T. Nguyen, PhD1,11 and Michael G. Kharas, PhD5

1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, NY
3Weill Cornell Graduate School of Medical Sciences, NY
4Memorial Sloan Kettering Cancer Center, New York
5Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York City, NY
6Memorial Sloan Kettering Cancer Center, ny
7Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York
8Memorial Sloan-Kettering Cancer Center, Vancouver, BC, Canada
9The University of British Columbia, Vancouver, BC, Canada
10Simon Fraser University, Vancouver, BC, Canada
11Center for Hemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Ryan B. Day, MD, PhD, Sai Mukund Ramakrishnan, MS*, Christopher A Miller, PhD* and Timothy J Ley, MD

Department of Internal Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University in St. Louis School of Medicine, Saint Louis, MO

Karina Hamamoto, PhD1, Ganqian Zhu2*, Julia Lesperance1*, Huacheng Luo, PhD1*, Ying D Li, PhD2*, Nupur Nigam3*, Arati Sharma, PhD, MSc4*, Feng-Chun Yang, MD, PhD5, David F. Claxton, MD6,7, Yi Qiu, PhD7,8, Peter D. Aplan, MD9, Mingjiang Xu, MD, PhD2 and Suming Huang, PhD1,7

1Division of Pediatric Hematology/Oncology, Pennsylvania State University College of Medicine, Hershey, PA
2Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX
3Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD
4Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA
5Department of Cell Systems and Anatomy, University of Texas Health Science Center, San Antonio, TX
6Division of Hematology/Oncology, Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA
7Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA
8Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA
9Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Shiyu Xiao1, Hongxia Chen, MD/PhD1*, Michihiro Kobayashi, M.D, Ph.D.2, Yunpeng Bai3*, Sergio Barajas1,2, Wenjie Cai1,2, Zhong-Yin Zhang, PhD3* and Yan Liu, PhD1

1Northwestern University, Chicago, IL
2Indiana University, Indianapolis, IN
3Purdue University, West Lafayette, IN

Rebecca Briggs*, Hayley McMillan, BSc, PhD*, Lydia E Roets, BSc, PhD*, Kienan I Savage, Prof., PhD* and Katrina M Lappin, PhD*

Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, NI, United Kingdom

Dipanjali Saha, MSc1*, Anne Angelillo-Scherrer2 and Ramanjaneyulu Allam3*

1Department of BioMedical Research; Department of Hematology, University of Bern, Bern University Hospital (Inselspital Bern), Bern, AE, Switzerland
2Inselspital, Bern University Hospital, Bern, Switzerland
3Department of BioMedical Research, Department of Hematology, University of Bern, Bern University Hospital (Inselspital), Bern, Switzerland

Samantha A Swenson1, Arjun Dhir, MSc1, Isabelle S Weber2*, Kasidy K Dobish3*, Peng Xiao, PhD4*, Shannon M. Buckley, PhD3 and Kate Hyde, PhD1

1Department of Biochemistry and Molecular Biology, and Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE
2University of Nebraska-Omaha, Omaha, NE
3University of Utah, SLC, UT
4Department of Genetics, Cell Biology, and Anatomy, and UNMC Bioinformatics and Systems Biology Core, University of Nebraska Medical Center, Omaha, NE

Matthew Markham, PhD1*, Rebecca S Maynard, MSc1*, George Bell1*, Katherine Hampton, MSc, BSc1*, Dominic James Fowler-Shorten, MRes, BSc1*, Alyssa Nicole Polski-Delve, MSc, BSc1*, Annalisa Altera, PhD1*, Rosie Taylor1*, Charlotte Hellmich, PhD, BSc, MBBChir1,2, Kristian Bowles, MBBS, PhD1,2 and Stuart A Rushworth, PhD3

1Norwich Medical School, University of East Anglia, Norwich, United Kingdom
2Norfolk and Norwich University Hospital, Norwich, United Kingdom
3The University of East Anglia, Norwich, United Kingdom

Shiva Bamezai, PhD1*, Jing He1*, Pradeep Rajput, PhD2*, Deniz Sahin, MSc1*, Alex Jose Pulikkottil1*, Fabian Mohr1*, Mahalakshmi Naidu Vegi, PhD, MSc1*, Rana Pratap Singh, PhD3*, Deepshi Thakral, PhD4*, Ritu Gupta, MD4*, Christian Buske, MD1 and Vijay Pal Singh Rawat, PhD2*

1Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany, Ulm, Germany
2Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India, New Delhi, India
3School of Life Sciences, Jawaharlal Nehru University, New Delhi, India, Delhi, India
4Laboratory Oncology, Dr. BRA. IRCH, All India Institute of Medical Sciences, New Delhi, India, New Delhi, India

Lilia Cabrera-Cosme1*, Juan Rubio-Lara1,2*, Ellie Bennett1*, Joanna Milek1*, Maria Jassinskaja1*, Sandy MacDonald3*, Karen Hogg4*, Nicola K. Wilson2*, Berthold Gottgens2 and David Kent1*

1Centre for Blood Research, York Biomedical Research Institute, University of York, York, United Kingdom
2Department of Hematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
3Data Science Hub, Technology Facility, University of York, York, United Kingdom
4Imaging and Cytometry Laboratory, Technology Facility, University of York, York, United Kingdom

Ayana Kon, MD, PhD1,2,3, Masahiro M Nakagawa, MD, PhD1, Azumi Tomita, BA1*, Keisuke Kataoka, MD, PhD4,5, Nobuyuki Kakiuchi, MD, PhD1,6*, Manabu Nakayama, MD, PhD7*, Haruhiko Koseki, MD, PhD8*, Hideki Makishima, MD, PhD1,9, Yasuhito Nannya, MD, PhD1,10 and Seishi Ogawa, MD, PhD11

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2The University of Tokyo, Tokyo, Japan
3Division of Stem Cell and Genome Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
5Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
6The Hakubi Center for Advanced Research, Kyoto University, Kyoto, Japan, Kyoto, Japan
7Chromosome Engineering Team, Department of Technology Development, Kazusa DNA Research Institute, Chiba, Japan
8Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
9Department of Hematology and Medical Oncology, Shinshu University, Matsumoto, Japan
10Institute of Medical Science Hospital, Department of Hematology-Oncology, The University of Tokyo, Tokyo, Japan
11Kyoto University, Sakyoku, KYO, Japan

Giulia Biancon, PhD1,2, Emma Busarello3*, Matthew Cheng1*, Simone Sidoli, PhD4*, Jennifer VanOudenhove, PhD5, Giorgia Bucciarelli3*, Toma Tebaldi, PhD3* and Stephanie Halene, MD6

1Yale University, New Haven, CT
2Policlinico Hospital of Milan, Milan, Italy
3University of Trento, Trento, Italy
4Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY
5Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
6Yale Univ. School of Medicine, New Haven, CT

Moussa Diolombi1*, Anish V Sharda, MBBS2, Ming Chen, PhD3*, Leinal Sejour4*, Assaf Bester, PhD5*, Daphna Nachmani, PhD6*, John G. Clohessy, PhD7*, Pier Paolo Pandolfi, MD PhD8* and Lourdes M Mendez, MD, PhD9*

1University of Queensland, Brisbane, Australia
2Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT
3Duke University School of Medicine, Durham, NC
4BIDMC, Boston, MA
5Technion, Haifa, Israel
6The Hebrew University of Jerusalem, Jerusalem, ISR
7Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
8Universita di Torino, Torino, Italy
9Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT

Michael Rassner1*, Tony Müller, PhD2*, Kirstyn Anne Crossley1*, Geoffroy Andrieux, PhD3*, Lena Jakob1*, Alina Müller-Rudorf1*, Natalie Koehler1*, Robert A. J. Oostendorp, PhD4, Gerhard Müller-Newen, PhD5*, Katharina Schönberger6*, Nina Cabezas-Wallscheid, PhD6*, Irene Gonzalez-Menendez7*, Leticia Quintanilla-Fend, MD7, Olaf Groß8*, Oliver Gorka8*, Marie Follo1*, Anna Lena Illert9*, Melanie Boerries, MD, PhD10*, Robert Zeiser, MD1 and Justus Duyster, MD11*

1Department of Medicine I, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Department I of Internal Medicine, Center for Integrated Oncology, Aachen-Bonn-Cologne-Duesseldorf, University of Cologne, Cologne, Germany, Cologne, DEU
3Institute of Medical Bioinformatics, University Medical Center Freiburg, Freiburg, Germany
4Technical University Munich (Klinikum Rechts der Isar), Munchen, DEU
5Confocal Microscopy Facility, Interdisciplinary Center for Clinical Research IZKF, RWTH Aachen University, Aachen, Germany
6Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
7Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen, Germany
8Institute of Neuropathology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, Freiburg, Germany
9Department of Medicine III, Klinikum Rechts der Isar, Faculty of Medicine, Technical University of Munich, Munich, Germany
10Institute of Medical Bioinformatics and Systems Medicine, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
11Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

*signifies non-member of ASH